by Clinical Neuropsychologist Online | Wednesday, September 2, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 9, September 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 2, 2026 Neuro-Dementia...
by Clinical Neuropsychologist Online | Tuesday, September 1, 2026 | Dementia
Abstract INTRODUCTION Plasma phosphorylated tau (p-tau), particularly p-tau217, is a highly specific biomarker of Alzheimer’s disease (AD) pathology. However, plasma p-tau217 can be elevated in rare non-AD conditions. Brain-derived (BD) p-tau217 may reduce these...
by Clinical Neuropsychologist Online | Monday, August 31, 2026 | Dementia
Abstract INTRODUCTION We tested whether quantitative transport mapping (QTM)-derived perfusion velocity would detect earlier and more sex-specific microvascular alterations than cerebral blood flow (CBF) across the Alzheimer’s disease (AD) continuum. METHODS In...
by Clinical Neuropsychologist Online | Monday, August 31, 2026 | Dementia
Abstract INTRODUCTION Repetitive head impacts (RHIs) have been linked to later life neurodegeneration, yet the in vivo structural correlates of cumulative biomechanical loading remain unclear. We examined whether regional ventricular morphology in former American...
by Clinical Neuropsychologist Online | Monday, August 31, 2026 | Dementia
Abstract As dementia prevalence rises, developing a dementia-capable workforce is a national priority. Training requirements vary widely across states, and many memory care staff receive limited dementia education. Although evidence supports dementia training, little...
by Clinical Neuropsychologist Online | Monday, August 31, 2026 | Dementia
Abstract Artificial intelligence (AI) is rapidly entering dementia clinical practice, offering opportunities across the care continuum. However, cognitive decline creates a unique ethical challenge. This perspective article proposes a strategy to ensure the...